RECURSION PHARMACEUTICALS, INC. reports

Company location: Salt Lake City, UT
Fiscal year end: 31 December

RECURSION PHARMACEUTICALS, INC. has filed 940 SEC EDGAR filings since 02 Apr 2014

Filter by type:
10-K
10-Q
8-K
SC13D
SC13G

SEC filing history

Showing 151-175 of 940 matching filings.

Per page

25

Current page

7

4

FORM 4

Filing date: 03 Jul 2025
Reporting date: 01 Jul 2025
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 23 Jun 2025
Reporting date: 18 Jun 2025
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 23 Jun 2025
Reporting date: 18 Jun 2025
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 23 Jun 2025
Reporting date: 18 Jun 2025
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 23 Jun 2025
Reporting date: 18 Jun 2025
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 23 Jun 2025
Reporting date: 18 Jun 2025
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 23 Jun 2025
Reporting date: 18 Jun 2025
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 23 Jun 2025
Reporting date: 18 Jun 2025
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 18 Jun 2025
Reporting date: 16 Jun 2025
SEC evidence: Open document Open filing
Next action: Verify source filing

8-K File 001-40323

8-K

Filing date: 18 Jun 2025
Reporting date: 18 Jun 2025
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

8-K File 001-40323

8-K

Filing date: 10 Jun 2025
Reporting date: 10 Jun 2025
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

4

FORM 4

Filing date: 19 May 2025
Reporting date: 15 May 2025
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 19 May 2025
Reporting date: 15 May 2025
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 19 May 2025
Reporting date: 15 May 2025
SEC evidence: Open document Open filing
Next action: Verify source filing

8-K File 001-40323

8-K

Filing date: 09 May 2025
Reporting date: 09 May 2025
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

424B7 File 333-284878

424B7

Filing date: 09 May 2025
Reporting date: Not listed
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

S-8 File 333-286963

S-8

Filing date: 05 May 2025
Reporting date: Not listed
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

10-Q File 001-40323

10-Q

Filing date: 05 May 2025
Reporting date: 31 Mar 2025
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

8-K File 001-40323

8-K

Filing date: 05 May 2025
Reporting date: 05 May 2025
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

ARS File 001-40323

ARS

Filing date: 28 Apr 2025
Reporting date: 31 Dec 2024
SEC evidence: Open document Open filing
Next action: Verify source filing

DEFA14A File 001-40323

DEFA14A

Filing date: 28 Apr 2025
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

DEF 14A File 001-40323

DEF 14A

Filing date: 28 Apr 2025
Reporting date: 28 Apr 2025
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

4

FORM 4

Filing date: 03 Apr 2025
Reporting date: 01 Apr 2025
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 03 Apr 2025
Reporting date: 01 Apr 2025
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 03 Apr 2025
Reporting date: 01 Apr 2025
SEC evidence: Open document Open filing
Next action: Verify source filing

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. to update or revoke optional consent for future visits. For more information, see our Privacy Policy .